Recent Publications

See Dr. Vuk-Pavlovic's publications on PubMed

  • Dietz, A.B., Bulur, P.A., Erickson, M.R., Wettstein, P.J., Litzow, M.R., Wyatt, W.A., Dewald, G.W., Tefferi, A., Pankratz, V.S. and Vuk-Pavlovic, S. (2000). Optimizing preparation of normal dendritic cells and bcr-abl positive mature dendritic cells derived from immunomagnetically purified CD14 positive cells. J. Hematother. Stem Cell Res. 9, 95-101.
  • Burch, P.A., Breen, J.K., Buckner, J.C., Gastineau, D.A., Kaur, J.A., Laus, R.L., Padley, D.J. Peshwa, M.V., Pitot, H.C., Richardson, R.L., Smits, B.J., Sopapan, P., Strang, G., Valone, F.H. and Vuk-Pavlovic, S. (2000). Priming tissue-specific cellular immunity in a phase I trial of autlogous dendritic cells for prostate cancer. Clin. Cancer Res. 6, 2175-2182.
  • Bajzer, Z., Dietz, A. B. and Vuk-Pavlovic, S. (2000). New dimensions in Gompertzian growth. J. Theor. Med. 2, 307-315.
  • Matasic, R., Dietz, A.B. and Vuk-Pavlovic, S. (2000). Cyclooxygenase independent inhibition of dendritic cell maturation by aspirin. Immunology 101, 53-60.
  • Dietz, A.B., Bulur, P.A., Knutson, G.J., Matasic, R. and Vuk-Pavlovic, S. (2000). Maturation of human monocyte-derived dendritic cells stuied by microarray hybridization. Biochem. Biophys. Res. Commun. 275, 731-738.
  • Dietz, A.B., Bulur, P.A., Brown, C.A., Pankratz, V.S. and Vuk-Pavlovic, S. (2001). Maturation of dendritic cells infected by recombinant adenovirus can be delayed without impact on transgene expression. Gene Ther. 8, 419-423.
  • Dietz, A.B., Litzow, M.R., Bulur, P.A. and Vuk-Pavlovic, S. (2001). Transgenic interleukin 2 secreted by CML dendritic cells stimulates autlogous TH1 T cells. Cytotherapy 3, 97-105.
  • Dietz, A.B., Litzow, M.R., Gastineau, D.A. and Vuk-Pavlovic, S. (in press). Engineering dendritic cells grafts for clinical trials in cellular immunotherapy of cancer: the example of chronic myelogenous leukemia. Croat. Med. J. 42, 427-434.
  • Padley, D.J., Dietz, A.B., Gastineau, D.A. and Vuk-Pavlovic, S. (2001). Mature myeloid dendritic cells for clinical use prepared from CD14-positive cells isolated by immunomagnetic adsorption. J. Hematother. Stem Cell Res. 10, 427-429.
  • Matasic, R., Dietz, A.B. and Vuk-Pavlovic, S. (2001). Maturation of human dendritic cells as sulfasalazine target. Croat. Med. J. 42, 440-445.
  • Fisher, P.J. Springett, M.J., Dietz, A.B., Bulur, P.A. and Vuk-Pavlovic, S. (2002). Immunomagnetic separation reagents as markers in electron microscopy. J. Immunol. Methods 262(1-2):95-101.
  • Dietz, A.B., Litzow, M.R., Bulur, P.A. and Vuk-Pavlovic, S. (2002). Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells. Cytotherapy 3(2), 97-105.
  • Antica, M., Kusic, B., Hranilovic, D., Dietz, A.B. and Vuk-Pavlovic, S. (2002). Cloning the cDNA for murine U2 snRNP-AÕ gene and its differential expression in lymphocyte development. Immunol. Lett. 82(3), 217-223.
  • Burch, P.A., Croghan, G.A., Gastineau, D.A., Jones, L.A., Kaur, J.S., Kylstra, J.W., Richardson, R.L., Valone, F.H., Vuk-Pavlovic, S.: Immunotherapy (APC8015, Provenge ï) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A phase 2 trial. The Prostate, in press, 2004.
  • Bajzer, Z., Vuk-Pavlovic, S.: Cell interactions as positive regulatory feedbacks. Submitted for publication.
  • Decker, G.A., Dietz, A.B., Gores, G.J., Nyberg, S.L., Vuk-Pavlovic, S.: Serum levels of vascular endothelial growth factor and stem cell factor in the course of liver regeneration in humans. Submitted for publication.
  • Dietz, A.B., Bulur, P.A., Knutson, G.J., Souan, L., Litzow, M.R., Vuk-Pavlovic, S.: Imatinib mesylate inhibits proliferation of T cells in vitro and delayed-type hypersensitivity in vivo. Submitted for publication.
  • Dietz, A.B., Fisher, P.J., Bulur, P.A., Knutson, G.J., Prendergast, F.G., Vuk-Pavlovic, S.: Morphology of dendritic cell-T cell interaction site. Submitted for publication.